Fighting the FDA’s Final Rule on LDTs
CEO Laurie Menser discusses the Association for Molecular Pathology’s court case against the FDA’s rule on laboratory-developed tests.
Top of the News-lir
Subscribe today for access to
Articles and Reports
Getting Started with the FDA’s New LDT Rule
Experts explain what the phase-in process will look like—and how labs can get ahead of the game.
Transitioning the Clinical Lab
What clinical laboratory professionals need to know about healthcare provision for transgender and nonbinary patients
Lab Sector Jobs Grow by 25 Percent Over Last Decade
...
Already a member? Log in here
ACLA Uses Cancer Initiative to Lobby on PAMA, LDTs
...
Already a member? Log in here
PAML Campaign Encourages Men to Seek Routine Testing
...
Already a member? Log in here
Abbott to Acquire Alere for $5.8 Billion in Point-of-Care Play
From - Laboratory Industry Report
Abbott (Abbott Park, Ill.) is betting big on point-of-care testing. The global healthcare giant announced on Feb. 1 its agreement to acquire Alere (Waltham, Mass.) for…
Survey Says Many Hospitals Are Reluctant to Adopt Precision
...
Already a member? Log in here
Theranos Encounters More Regulatory Obstacles in Its National Buildout
...
Already a member? Log in here
Magellan Lends Lead Testing Platforms to Flint
...
Already a member? Log in here
- « Previous
- 1
- …
- 10
- 11
- 12